Lapatinib 250mg Tablets Brands India

What is Lapatinib? 

Lapatinib 250mg (Tykerb) is targeted cancer therapy, it is an orally active drug. It is a dual tyrosine kinase inhibitor used in combination therapy for HER2 positive breast cancer. in 2007 it is approved by the FDA to treat breast cancer patients. 

Lapatinib 250mg Tablets Uses : 

It is used to treat Breast cancer and also patients with metastatic breast cancer whose tumor overexpresses HER2. 

Lapatinib Tablets Brands in India : 

Tykerb 250mg Tablets by GSK and Novartis. 

Herduo 250mg Tablets (30 and 150 Tablets) by Natco Pharma 

Abnib 250mg Tablets by Abbott Labs 

Combinib 250mg Tablets by Cipla Ltd. 

Herlapsa 250mg Tablets by Mylan Pharma

Hertab 250mg Tablets (30 and 150 tablets) by Hetero Oncology 

Lapahope 250mg Tablets by Glenmark Pharma 

Lapatem 250mg Tablets (30 and 120 Tablets) by Emcure Pharmaceuticals 

Lapatinib Side Effects : 

Nausea, Headache, Weakness, Back Pain, Fatigue, Constipation, Loss of Appetite, Mouth Sores, Rashes, etc. 

Seek medical attention right away and consult with your doctor.